Pharming Group (PHARM) Financial Statements

29 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently €765.58M. The company's EPS TTM is €0.0195; its P/E ratio is 76.73; Pharming Group is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 391.47M	€ 297.07M	€ 245.32M	€ 205.62M	€ 198.87M
Gross Profit	€ 344.11M	€ 261.80M	€ 220.10M	€ 188.06M	€ 177.73M
Operating Income	€ 20.10M	€ -3.67M	€ -4.88M	€ 18.23M	€ 19.01M
EBITDA	€ 31.77M	€ 13.65M	€ 9.88M	€ 33.53M	€ 55.30M
Net Income	€ 2.97M	€ -11.02M	€ -10.55M	€ 13.67M	€ 18.13M
Balance Sheet
Cash & Short-Term Investments	€ 179.88M	€ 167.82M	€ 213.42M	€ 208.58M	€ 191.92M
Total Assets	€ 500.02M	€ 400.61M	€ 462.85M	€ 425.80M	€ 449.97M
Total Debt	€ 115.79M	€ 112.26M	€ 171.54M	€ 167.69M	€ 161.76M
Net Debt	€ -30.29M	€ 57.34M	€ 109.80M	€ -40.65M	€ -34.16M
Total Liabilities	€ 222.89M	€ 178.85M	€ 244.07M	€ 221.16M	€ 231.49M
Stockholders' Equity	€ 277.10M	€ 221.76M	€ 218.78M	€ 204.64M	€ 192.92M
Cash Flow
Free Cash Flow	€ 51.18M	€ -2.58M	€ -18.77M	€ 20.92M	€ 22.86M
Operating Cash Flow	€ 51.96M	€ -1.79M	€ -17.30M	€ 22.90M	€ 40.96M
Investing Cash Flow	€ 19.13M	€ 32.74M	€ -129.39M	€ 5.32M	€ -23.06M
Financing Cash Flow	€ 15.03M	€ -35.63M	€ -1.04M	€ -4.98M	€ -27.84M

Currency in EUR

Pharming Group Earnings and Revenue History

Income Statement >

Pharming Group Debt to Assets

Balance Sheet >

Pharming Group Cash Flow

Cash Flow >

Pharming Group Forecast EPS vs Actual EPS

Earnings >